Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 98 of 178 for:    LENALIDOMIDE AND Leukemia

Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL) (Phase I BLR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00864942
Recruitment Status : Completed
First Posted : March 19, 2009
Last Update Posted : March 13, 2015
Sponsor:
Collaborators:
Celgene Corporation
Cephalon
Information provided by (Responsible Party):
Georgetown University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2014
Actual Study Completion Date : October 2014